Screener
GeneDx Holdings WGS EBIT
Discontinued — last reported Q1 '26
EBIT at other companies
Other financials
Where this comes from
Calculated from GeneDx Holdings’s reported figures.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
FAQ
- What is GeneDx Holdings's EBIT?
- GeneDx Holdings (WGS) reported EBIT of -$57.47M in Q1 2026.
- How has GeneDx Holdings's EBIT changed year-over-year?
- GeneDx Holdings's EBIT decreased by 1162.8% year-over-year, from -$4.55M to -$57.47M.
- What is the long-term trend for GeneDx Holdings's EBIT?
- Over 3 years (2021 to 2025), GeneDx Holdings's EBIT has grown at a -60.2% compound annual growth rate (CAGR), from -$207.17M to -$13.08M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about GeneDx Holdings's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude